On data sharing in computational drug discovery and the need for data notes
Related Experiment Video
Updated: Apr 18, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
1Department of Life Science Informatics, B-IT, LIMES Program Unit Chemical Biology and Medicinal Chemistry, Rheinische Friedrich-Wilhelms-Universität, Dahlmannstr, Bonn, D-53113, Germany.
Abstract:
In the big data era, the scientific community is in need of better practices and infrastructures for data deposition and sharing. In addition, scientific journals are challenged with formulating, implementing, and enforcing commonly accepted data deposition guidelines and addressing problems associated with the use of proprietary data. Furthermore, new publication formats are required to specifically focus on data, their organization, and related issues and raise awareness of data heterogeneity and complexity. Such types of publications should also present a forum for evaluating and discussing specifics of data upon which follow-up investigations are based. Data articles/notes introduced by F1000Research represent an important step in the right direction.
More Related Videos
08:49Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
07:40A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Related Concept Videos
Drug Discovery: Overview
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Bioequivalence Data: Statistical Interpretation
Pharmacogenomics: Identification of New Drug Targets
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Nomenclature